Formation of mixed aggregates of human polymorphonuclear leukocytes and platelets by C5a-desArg.
Human blood platelets are not aggregated by C5a-desArg. They are brought to aggregation, however, when human polymorphonuclear leukocytes (PMN) are present in the platelet suspension. Then, mixed aggregates form upon activation with C5a-desArg. The platelets do not adhere only to PMN but also stick to each other, indicating that they are activated. This is also evident from their morphology which shows pseudopod formation. The formation of mixed aggregates requires the presence of Ca2+ and Mg2+, it does not occur at temperatures below 20 degrees C. The results suggest that the platelets are activated indirectly, by a mediator released from the PMN upon stimulation with C5a-desArg. When mixed with platelets, PMN partially aggregate already upon addition of Ca2+. This effect is not seen in pure PMN suspensions. C5a-desArg causes additional aggregation which includes the platelets. The indirectly stimulated platelets in turn enhance the aggregation of the PMN in the mixtures incubated with C5a-desArg. This may cause a positive feedback.
Damerau
B
B
Max-Planck-Institut für experimentelle Medizin, Göttingen, FRG.
Meyer
B
B
Vogt
W
W
D002449:Cell Aggregation / Q000502:physiology; D015937:Complement C5a, des-Arginine / Q000502:physiology*; D006801:Humans; D066298:In Vitro Techniques; D009504:Neutrophils / Q000502:physiology*; D010974:Platelet Aggregation / Q000502:physiology*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology; D012128:Respiratory Distress Syndrome / Q000097:blood
D015937:Complement C5a, des-Arginine; D010975:Platelet Aggregation Inhibitors